Company Overview
Snapshot
Founded in February 2021 by Yossi Gross, Discure Technologies operates with 11–50 employees. The company has raised $21 million across 3 funding rounds from 7 investors.
Business overview
Discure Technologies is a Health Tech & Life Sciences company focused on developing medical technologies to treat degenerative disc disease. The company's core product is a minimally invasive device designed to reverse the condition, reduce pain, and restore functionality, aiming to eliminate the need for invasive surgery and decrease opioid reliance. Discure Technologies operates within the Medical Devices, and Medical Treatment & Therapeutics sectors, serving patients and providers in the healthcare industry.
Strategic signal
This funding, alongside participation from Sanara Capital and Supernova Invest, signals strong investor confidence in the company's minimally invasive device for degenerative disc disease. The continued financial backing suggests a positive trajectory for Discure Technologies' R&D and market entry, highlighting its potential to disrupt traditional surgical approaches and opioid-based pain management in the healthcare sector.
Log in to access full profile ›Company Intelligence Q&A
- When was Discure Technologies founded?
- Discure Technologies was founded in February 2021.
- Who founded Discure Technologies?
- Discure Technologies was founded by Yossi Gross.
- What is Discure Technologies' primary focus?
- Discure Technologies focuses on developing a minimally invasive device to treat and reverse degenerative disc disease, aiming to reduce pain and restore functionality without invasive surgery or reliance on opioids.
- What was Discure Technologies' most recent funding event?
- In September 2024, Discure Technologies secured an A Round of funding from investors including.
- Which investors participated in Discure Technologies' Seed round?
- In March 2022, Discure Technologies received Seed funding from investors including.